Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M McDaneld

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|August 26, 2017
Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?Samuel L Aitken, Farnaz Foolad, Patrick M McDaneld
Antimicrobial Agents and Chemotherapy|September 27, 2021
Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic MalignancyAdam J DiPippo, Patrick M McDaneld, Frank P Tverdek, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2019
Serum Levels of Crushed Posaconazole Delayed-Release TabletsMathew J Mason, Patrick M McDaneld, William L Musick, et al.
The Annals of Pharmacotherapy|November 22, 2013
Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mLPatrick M McDaneld, Linda M Spooner, John F Mohr, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 19, 2014
Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levelsSteven D Burdette, Frederick Oleson, Patrick M McDaneld, et al.
Diagnostic Microbiology and Infectious Disease|January 20, 2026
Real-world laboratory functionality requirements and implementation considerations for fast phenotypic antimicrobial susceptibility testingPatrick M McDaneld, Theresa Okeyo Owuor, Shivaramu Keelara, et al.
Journal of Pharmacy Practice|August 27, 2021
Significant Publications on Infectious Diseases Pharmacotherapy in 2020Taryn A Eubank, Noor Zaidan, Faris S Alnezary, et al.
Journal of Pharmacy Practice|August 30, 2017
Significant Publications on Infectious Diseases Pharmacotherapy in 2016Gary Fong, Erik W Skoglund, Kady Phe, et al.
Open Forum Infectious Diseases|May 27, 2024
Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer CenterFrank P Tverdek, Samuel L Aitken, Victor E Mulanovich, et al.
Journal of Pharmacy Practice|July 23, 2019
Significant Publications on Infectious Diseases Pharmacotherapy in 2018Jovan Borjan, Anne J Gonzales-Luna, Travis J Carlson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|August 26, 2017
Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?Samuel L Aitken, Farnaz Foolad, Patrick M McDaneld
Antimicrobial Agents and Chemotherapy|September 27, 2021
Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic MalignancyAdam J DiPippo, Patrick M McDaneld, Frank P Tverdek, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2019
Serum Levels of Crushed Posaconazole Delayed-Release TabletsMathew J Mason, Patrick M McDaneld, William L Musick, et al.
The Annals of Pharmacotherapy|November 22, 2013
Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mLPatrick M McDaneld, Linda M Spooner, John F Mohr, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 19, 2014
Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levelsSteven D Burdette, Frederick Oleson, Patrick M McDaneld, et al.
Diagnostic Microbiology and Infectious Disease|January 20, 2026
Real-world laboratory functionality requirements and implementation considerations for fast phenotypic antimicrobial susceptibility testingPatrick M McDaneld, Theresa Okeyo Owuor, Shivaramu Keelara, et al.
Journal of Pharmacy Practice|August 27, 2021
Significant Publications on Infectious Diseases Pharmacotherapy in 2020Taryn A Eubank, Noor Zaidan, Faris S Alnezary, et al.
Journal of Pharmacy Practice|August 30, 2017
Significant Publications on Infectious Diseases Pharmacotherapy in 2016Gary Fong, Erik W Skoglund, Kady Phe, et al.
Open Forum Infectious Diseases|May 27, 2024
Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer CenterFrank P Tverdek, Samuel L Aitken, Victor E Mulanovich, et al.
Journal of Pharmacy Practice|July 23, 2019
Significant Publications on Infectious Diseases Pharmacotherapy in 2018Jovan Borjan, Anne J Gonzales-Luna, Travis J Carlson, et al.
Pageof 2